Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but the effects of continual use on neural substrates are fairly unexplored and long-term effects are unknown. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernaerts, Sylvie, Boets, Bart, Steyaert, Jean, Wenderoth, Nicole, Alaerts, Kaat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648620/
https://www.ncbi.nlm.nih.gov/pubmed/33159033
http://dx.doi.org/10.1038/s41398-020-01069-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648620/
https://www.ncbi.nlm.nih.gov/pubmed/33159033
http://dx.doi.org/10.1038/s41398-020-01069-w

Ejemplares similares